The purpose of this study is to determine: * Condition of intensive care unit (ICU) admission in patients with haematological malignancies. * ICU hospital and up to one year mortality. * Assessment of post ICU burden and health related quality at 90-d and 1 year.
1. To identify prognostic factors of short and medium term mortality, by underlining the respective weights of organ dysfunction and characteristics of underlined malignancy 2. Evaluate the health related quality of life of intensive care survivors(SF36) 3. Impact of intensive care on families burden (HADS, IES). 4. Assess clinicians' satisfaction ( intensivists, haematologists and intensive care nurses) in relation to medical decision-making. 5. Establish the relevance of antifungal treatments.
Study Type
OBSERVATIONAL
Enrollment
1,011
Hôpital Saint-Louis, AP-HP
Paris, France
Survival status at one year
survival status (alive or death) at one year
Time frame: 1 year
Health related quality of life of patients and their relatives
Time frame: day 90 and 1 year
ICU mortality
survival status at ICU discharge
Time frame: 1 week (estimated mean time until ICU discharge)
Survival status
Time frame: day 90
Hospital mortality
survival status at hospital discharge
Time frame: 3 weeks (estimated mean time until Hospital discharge)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.